NKX2-5 and acute lymphoblastic leukemia: In contrast, NKX2-5 activates the developmental regulator MEF2C which is involved in the differentiation of cardiomyocytes and B-cells but not of T-cells and represents a strong oncogene in T-ALL [48,49].